|
Volumn 47, Issue 1, 2001, Pages 120-121
|
In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients [5]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 NITROPHENYLPHOSPHATASE;
ACID PHOSPHATASE;
ALLOPURINOL;
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIMONY DERIVATIVE;
LIQUID NITROGEN;
MEGLUMINE ANTIMONATE;
N 6260;
AMASTIGOTE;
ANIMAL CELL;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
CHEMOPROPHYLAXIS;
CLINICAL ARTICLE;
COHORT ANALYSIS;
COMORBIDITY;
CONTROLLED STUDY;
CULTURE MEDIUM;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
DRUG EFFICACY;
FRANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IC 50;
IN VITRO STUDY;
LEISHMANIA INFANTUM;
LETTER;
MOUSE;
NONHUMAN;
PARASITE ISOLATION;
PROMASTIGOTE;
RECURRENCE RISK;
SIDE EFFECT;
SPAIN;
STRAIN DIFFERENCE;
VISCERAL LEISHMANIASIS;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANIMALS;
ANTIPROTOZOAL AGENTS;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
LEISHMANIA INFANTUM;
LEISHMANIASIS, VISCERAL;
MEGLUMINE;
|
EID: 0035177382
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (17)
|
References (6)
|